Patents by Inventor Magali Faure

Magali Faure has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10137108
    Abstract: Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: November 27, 2018
    Assignee: Nestec S.A.
    Inventors: Stephanie Blum-Sperisen, Magali Faure, Denis Breuille, Emil Chuang
  • Publication number: 20180153842
    Abstract: A nutritional composition is used to reconstitute an optimal healthy microbiota ecosystem in humans or animals. In particular, an ingestible carrier contains specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. In another aspect, specific amino acids are used to reconstitute an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.
    Type: Application
    Filed: January 30, 2018
    Publication date: June 7, 2018
    Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
  • Patent number: 9884033
    Abstract: A nutritional composition is used to reconstitute an optimal healthy microbiota ecosystem in humans or animals. In particular, an ingestible carrier contains specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. In another aspect, specific amino acids are used to reconstitute an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: February 6, 2018
    Assignee: Nestec S.A.
    Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
  • Publication number: 20180021278
    Abstract: Methods and compositions are provided that treat or prevent inflammation using serine. A therapeutically effective amount of serine is administered to an individual, for example a human or other mammal, that has inflammation or is at risk of inflammation. The methods and compositions can control and/or alleviate an inflammatory reaction of the body, such as colitis.
    Type: Application
    Filed: January 22, 2016
    Publication date: January 25, 2018
    Inventors: Magali Faure, Stephanie Blum-Sperisen, Mohamed Nabil Bosco, Viral Brahmbhatt, Denis Breuille
  • Patent number: 9867391
    Abstract: The present invention generally relates to the field of medical nutrition. For example, the present invention provides a composition that can be used to treat, prevent and/or reverse muscle atrophy related to immobilization and its consequences. One embodiment of the present invention concerns a composition comprising a leucine and antioxidants that can be used in accelerating muscle recovery after muscle atrophy.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: January 16, 2018
    Assignee: Nestec S.A.
    Inventors: Dominique Dardevet, Isabelle Savary-Auzeloux, Didier Remond, Lydie Combaret, Gary Williamson, Magali Faure, Denis Breuille
  • Publication number: 20170370910
    Abstract: The present invention relates to a method for determining the distinctive nutritional requirements of a patient with specific nutritional needs and providing a composition meeting the distinctive nutritional requirements of said patient.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 28, 2017
    Inventors: Serge Andre Dominique Rezzi, Stephanie Blum-Sperisen, Magali Faure, Denis Breuille
  • Publication number: 20170368027
    Abstract: Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 28, 2017
    Inventors: Stephanie Blum-Sperisen, Magali Faure, Denis Breuille, Emil Chuang
  • Publication number: 20170368026
    Abstract: Methods and compositions are provided that use proline, serine and threonine to promote healing of the intestinal mucosa. A therapeutically effective amount of proline, serine and threonine is administered to an individual in need thereof, for example a human or other mammal, such as an individual that has damaged intestinal mucosa. The methods and compositions can promote mucosal healing, restore gut barrier function, repair intestinal epithelial cells, promote protection of the colonic epithelium, and/or promote the replenishment of goblet cells in the intestinal and colonic mucosa.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 28, 2017
    Inventors: Magali Faure, Stephanie Blum-Sperisen, Mohamed Nabil Bosco, Viral Brahmbhatt, Denis Breuille
  • Publication number: 20160310557
    Abstract: The invention relates to modified sweet whey protein (MSWP) for promoting the establishment of healthy and normal cognitive function in young mammals. In particular, the invention relates to the use of MSWP for promoting development of the brain structures responsible for cognitive functions (e.g. cortex and its associated neural pathways) and/or to reverse retardation and/or to prevent retardation of the establishment of cognitive functions. Humans or animals and, in particular, a foetus, pre- term or term born infant, toddler or child or a young adult may benefit from the invention.
    Type: Application
    Filed: December 12, 2014
    Publication date: October 27, 2016
    Applicant: NESTEC S.A.
    Inventor: Magali Faure
  • Publication number: 20160310533
    Abstract: The present invention relates to administration of sweet whey protein (SWP) for promoting the enteric neuronal development in infants, especially preterm, low birth, very low and extremely low birth weight infants as well as in young children up until the age of six. Administration of the SWP according to the invention prevents and treats disorders associated with an immature or impaired enteric nervous system. The disorders are, notably, dysfunctional gastrointestinal motility manifested as slow intestinal transit, intestinal discomfort, hard stools, constipation and/or gastrointestinal reflux, gut barrier dysfunction, food intolerance or necrotizing enterocolitis.
    Type: Application
    Filed: December 12, 2014
    Publication date: October 27, 2016
    Inventor: Magali Faure
  • Publication number: 20160128960
    Abstract: A nutritional composition is used to reconstitute an optimal healthy microbiota ecosystem in humans or animals. In particular, an ingestible carrier contains specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. In another aspect, specific amino acids are used to reconstitute an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.
    Type: Application
    Filed: January 14, 2016
    Publication date: May 12, 2016
    Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
  • Patent number: 9271958
    Abstract: The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. The invention also pertains to the use of specific amino acids for reconstituting an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: March 1, 2016
    Assignee: Nestec S.A.
    Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
  • Patent number: 9095570
    Abstract: The present invention relates generally to the field of neuronal health and neuronal protection. One embodiment of the present invention relates to a composition that can be used for the protection of the enteric nervous system from neurodegeneration. Disorders linked to an impaired enteric nervous system can be treated or prevented by the administration of lactoferrin containing compositions according to the present invention.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: August 4, 2015
    Assignee: Nestec S.A.
    Inventors: Magali Faure, Bing Wang, Jeroen Schmitt
  • Publication number: 20140363410
    Abstract: The invention relates to Lactobacillus reuteri DSM 17938 for promoting the establishment of healthy and normal cognitive function in young mammals. In particular, the invention relates to the use of Lactobacillus reuteri DSM 17938 for promoting development of the brain structures responsible for cognitive functions (e.g. cortex and hippocampus) and its associated neural pathways and/or to reverse retardation and/or to prevent retardation of the establishment of cognitive functions. Humans or animals and, in particular, a foetus, pre-term or term born infant, toddler or child or a young adult may benefit from the invention.
    Type: Application
    Filed: November 30, 2012
    Publication date: December 11, 2014
    Applicant: BioGaia AB
    Inventors: Gabriela Bergonzelli Degonda, Magali Faure, Nicole Kusy
  • Publication number: 20140363409
    Abstract: The invention relates to Lactobacillus reuteri DSM 17938, and compositions comprising Lactobacillus reuteri DSM 17938, for promoting the healthy development and/or repair of the enteric nervous system in mammals. Humans or animals and, in particular, a foetus, pre-term or term-born infant, toddler or child may benefit from the invention. The invention may be especially beneficial to those infants having experienced IUGR, or having a low, or very low birth weight, and/or suffered from enteric nervous system growth retardation either in utero or, during or after birth. The administration of to Lactobacillus reuteri DSM 17938 promotes normal and healthy neuronal and glial development. It also ensures healthy neuronal differentiation in the peripheral nervous system.
    Type: Application
    Filed: November 30, 2012
    Publication date: December 11, 2014
    Applicant: BioGaia AB
    Inventors: Gabriela Bergonzelli Degonda, Magali Faure, Nicole Kusy
  • Publication number: 20140335130
    Abstract: The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. The invention also pertains to the use of specific amino acids for reconstituting an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.
    Type: Application
    Filed: July 23, 2014
    Publication date: November 13, 2014
    Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
  • Publication number: 20140288004
    Abstract: The present invention generally relates to white matter. In particular, the present invention relates to a composition that can be used for promotion the development and/or void loss of white matter. One embodiment of the present invention relates to a composition comprising lactoferrin for use in the promotion of the development of the white matter, in the treatment or prevention of a delayed development of the white matter, and or in the treatment of prevention of a loss of white matter.
    Type: Application
    Filed: November 20, 2012
    Publication date: September 25, 2014
    Applicant: NESTEC S.A.
    Inventors: Bing Wang, Magali Faure
  • Publication number: 20140255511
    Abstract: The present invention generally relates to the field of medical nutrition. For example, the present invention provides a composition that can be used to treat, prevent and/or reverse muscle atrophy related to immobilization and its consequences. One embodiment of the present invention concerns a composition comprising a leucine and antioxidants that can be used in accelerating muscle recovery after muscle atrophy.
    Type: Application
    Filed: October 11, 2012
    Publication date: September 11, 2014
    Inventors: Dominique Dardevet, Isabelle Savary-Auzeloux, Didier Remond, Lydie Combaret, Gary Williamson, Magali Faure, Denis Breuille
  • Publication number: 20140135262
    Abstract: The present invention relates generally to the field of neuronal health and neuronal protection. One embodiment of the present invention relates to a composition that can be used for the protection of the enteric nervous system from neurodegeneration. Disorders linked to an impaired enteric nervous system can be treated or prevented by the administration of lactoferrin containing compositions according to the present invention.
    Type: Application
    Filed: November 6, 2013
    Publication date: May 15, 2014
    Applicant: NESTEC S.A.
    Inventors: Magali Faure, Bing Wang, Jeroen Schmitt
  • Publication number: 20130344045
    Abstract: The present invention provides a nutritional composition that is suitable to reduce the impact of stress on intestinal symptoms and/or conditions. The composition comprises one or more selected from a probiotic microorganism,one or more inactive probiotic, and one or more culture medium of one or more probiotic; and soluble fiber, and possibly other ingredients such as a milk ingredient, a source of carbohydrates and a source of protein. Preferably, the soluble fiber is a low viscosity soluble fiber. The composition is in particular suitable to alleviate abdominal discomfort, abdominal pain, abdominal cramps, and bowel movement disturbances, such as abdominal bloating, flatulence, in particular in as far as these conditions and symptoms are associated with stress.
    Type: Application
    Filed: December 28, 2011
    Publication date: December 26, 2013
    Applicant: NESTEC S.A.
    Inventors: Magali Faure, Gabriela Bergonzelli Degonda